FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40119111000001106: Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2043091000001112 Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2043101000001118 Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Is a House dust mites (Dermatophagoides pteronyssinus and Dermatophagoides farinae) allergen extract 12 SQ-HDM oral lyophilisates sugar free true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Is a Acarizax true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Has dispensed dose form Conventional release oral lyophilisate true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Has specific active ingredient Dermatophagoides farinae allergen extract true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Has specific active ingredient Dermatophagoides pteronyssinus allergen extract true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) 30 tablet 3 x 10 tablets Has AMP True Acarizax 12 SQ-HDM oral lyophilisates (ALK-Abello Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start